Autologue bone marrow mononuclear cell Therapy (Indonesia University)

N/A

Report date: 2022/11/15 12:33:49

Base Information

Drug NameAutologue bone marrow mononuclear cell Therapy (Indonesia University)

Drug Alias NameBM-MNC

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Immune system cell therapy > Leukocyte cell therapy > Monocyte cell therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionPancreatic beta cell replacements

TargetsNot applicable

Therapy Area/IndicationsIschemiaDiabetes Mellitus, Type 2Diabetes Mellitus

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryColombiaIndonesia

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesIndonesia University

China Registration ClassN/A

Develop Information

Active CompaniesFundación Oftalmológica de Santander Clínica Carlos Ardila Lulle

Inactive CompaniesIndonesia University

Active IndicationsIschemiaDiabetes Mellitus

Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A